Four of medtech’s biggest firms agreed to offer peripheral stents at specialized prices to members of SharedClarity, an organization formed through the alliance of some of the country’s largest health insurance and care providers.
Medtech giants Medtronic (NYSE:MDT), Covidien (NYSE:COV), Boston Scientific (NYSE:BSX) and Abbott (NYSE:ABT) all contracted with SharedClarity in the organization’s 2nd ground of agreements.
"These contracts are critical for the company and our members, who are already enjoying significant double-digit savings under our initial bare metal and drug-eluting stents contracts," SharedClarity president Mark West said in prepared remarks. "Now, with the peripherals contracts, we will continue to show how our unique approach benefits our members and customers, suppliers and, most of all, patients."
SharedClarity, formed just last year, is comprised of health benefits provider UnitedHealthcare and health care systems Advocate Health Care, Baylor Scott & White Health, Dignity Health and McLaren Health Care. SharedClarity is currently in talks with other health systems interested in becoming member-owners, the group said.
On the provider side, SharedClarity represents about 100,000 healthcare workers who care for roughly 7 million patients per year. On the insurer side, UnitedHealthcare has wide-reaching records on its 40 million members, including procedures they’ve undergone, lab results, physical therapy and more.
The group awarded its 1st round of contract earlier this year with Medtronic and Abbott.